348 related articles for article (PubMed ID: 16368286)
1. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
[TBL] [Abstract][Full Text] [Related]
2. Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials.
Mahaffey KW; Roe MT; Kilaru R; Alexander JH; Van de Werf F; Califf RM; Simoons ML; Topol EJ; Harrington RA
Eur Heart J; 2007 Feb; 28(4):425-32. PubMed ID: 17267458
[TBL] [Abstract][Full Text] [Related]
3. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
4. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.
Newby LK; Roe MT; Chen AY; Ohman EM; Christenson RH; Pollack CV; Hoekstra JW; Peacock WF; Harrington RA; Jesse RL; Gibler WB; Peterson ED;
J Am Coll Cardiol; 2006 Jan; 47(2):312-8. PubMed ID: 16412853
[TBL] [Abstract][Full Text] [Related]
6. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
[TBL] [Abstract][Full Text] [Related]
7. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
Yan AT; Yan RT; Tan M; Chow CM; Fitchett D; Stanton E; Langer A; Goodman SG;
Eur Heart J; 2004 Nov; 25(22):2006-12. PubMed ID: 15541836
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE).
Goodman SG; Steg PG; Eagle KA; Fox KA; López-Sendón J; Montalescot G; Budaj A; Kennelly BM; Gore JM; Allegrone J; Granger CB; Gurfinkel EP;
Am Heart J; 2006 Mar; 151(3):654-60. PubMed ID: 16504627
[TBL] [Abstract][Full Text] [Related]
9. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW
Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046
[TBL] [Abstract][Full Text] [Related]
10. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
Vikenes K; Melberg T; Farstad M; Nordrehaug JE
Scand Cardiovasc J; 2010 Apr; 44(2):69-75. PubMed ID: 19670037
[TBL] [Abstract][Full Text] [Related]
11. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
12. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain.
Storrow AB; Lindsell CJ; Han JH; Slovis CM; Miller KF; Gibler WB; Hoekstra JW; Peacock WF; Hollander JE; Pollack CV;
Ann Emerg Med; 2006 Dec; 48(6):660-5. PubMed ID: 17112930
[TBL] [Abstract][Full Text] [Related]
13. Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study.
Leoncini M; Toso A; Maioli M; Bellandi F; Badia T; Politi A; De Servi S; Dabizzi RP
Am Heart J; 2005 Sep; 150(3):401. PubMed ID: 16169315
[TBL] [Abstract][Full Text] [Related]
14. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina.
Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
Cardiology; 2009; 113(2):122-31. PubMed ID: 19039220
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes.
Bosch X; Théroux P
Am Heart J; 2005 Aug; 150(2):215-20. PubMed ID: 16086920
[TBL] [Abstract][Full Text] [Related]
17. Transition from CK-MB to troponin did not improve the 1 year mortality of non-ST elevation acute coronary syndromes.
Novack V; Jotkowitz AB; Cutlip D; Amit G; Liebermann N; Porath A
Postgrad Med J; 2008 Jan; 84(987):50-5. PubMed ID: 18230752
[TBL] [Abstract][Full Text] [Related]
18. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
[TBL] [Abstract][Full Text] [Related]
19. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
Ramsay J; Shernan S; Fitch J; Finnegan P; Todaro T; Filloon T; Nussmeier NA
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):300-6. PubMed ID: 15678039
[TBL] [Abstract][Full Text] [Related]
20. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
